November 10, 2016
Blue Cross Blue Shield Association (BCBS) and 40 other private health insurers could proceed with federal Racketeer Influenced and Corrupt Organizations Act (RICO) claims against GlaxoSmithKline (GSK) for injuries they allegedly sustained by spending billions of dollars on adulterated GSK drugs that were purchased in reliance on alleged misrepresentations that the drugs had been manufactured in accordance with federal safety...
The case is No. 13-4663.